Answers are grounded in this paper and cite their sources.
The challenge of assessing intracellular accumulation represents a major hurdle to the discovery of new antibiotics with Gram-negative activity. To address this, a high-throughput assay was developed to measure compound uptake and retention in Escherichia coli using LC/MS. 13,056 diverse small molecules were screened with two isogenic E. coli strains, a wild-type and a TolC-deleted mutant. Cell-associated concentrations of 8,410 compounds were determined and 6,416 compounds were classified either as retention-positive or -negative, with 45% (2,885) positives in the TolC mutant. Of these, 60% were not retained in the wild-type strain, indicating efficient efflux. No individual structural feature or physicochemical property explained the retention behavior. Machine learning (ML) models were trained using these results, and a gradient-boosted-tree model using 36 physicochemical compound descriptors proved most accurate. The ML model demonstrated robust performance across similar and dissimilar molecule subsets, showcasing its strong generalization and real-world predictive potential. An experimental validation of the tool was performed with a set of 540 new compounds and correctly predicted retention-positive cases in 77.8% and retention-negative in 74.4%. This assay and prediction tool could enhance Gram-negative antibiotic discovery, aiding in screening library design, computational structure-based drug design, and exploration of chemical space before synthesis.
No takes yet. Share an insight, caveat, or question.
Goff et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: